Answers are grounded in this paper and cite their sources.
Our findings should serve as a catalyst for large-scale investigations into bedinvetmab's risks and pharmacovigilance.
No takes yet. Share an insight, caveat, or question.
Farrell et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: